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Letter to the editor
Patient involvement vs. patient
participation in qualitative research in
the development of PROMs
I’m writing in response to a recent article pub-
lished in HEX: Wiering et al.1 I read this article
with great deal of interest, given the title and my
interest in patient involvement in research
and PROMs.
However, I felt a little concerned that the
article seemed to combine ‘patient involvement’
in the form of qualitative research to develop
PROMs and, to a lesser scale, patient involve-
ment as active involvement in research2 working
alongside the PROM development team. How-
ever, little detail was provided in the article on
the latter other than a few studies with ‘patient
involvement in developing the domains or
framework’ (although it is unclear exactly what
this involvement entailed).
The authors are correct to state that the views of
patients are key to developing PROMs and rightly
cited the FDA regulatory requirement for qualita-
tive research with patients to develop PROMs for
medical product development and regulatory
claims.3 This guideline advocates the use of (i)
open-ended concept elicitation interviews to estab-
lish the key concepts important and relevant to
patients for inclusion in a conceptual model and
framework forming the basis of the PROM con-
tent, and (ii) cognitive interviews with patients to
conﬁrm the face and content validity of a draft
PROM. However, there is a key role for patients
to be involved in the research and PROM devel-
opment process that seems to be missing from
this paper, or at least not emphasized enough.
For PROM development, patients can have
parallel, but notably diﬀerent roles: (i) as partic-
ipants in qualitative research to establish the
content and conﬁrm the content/face validity of
PROMs and (ii) as active members of the
research team working collaboratively in all
aspects of the PROM development to ‘enhance
the quality, relevance and acceptability of
PROMs’.4 The second role may include involve-
ment in a whole range of activities, such as:
 Reviewing the quality and acceptability of
existing PROMs (for a particular patient
group/research design)
 Identifying the need for the development of a
new PROM
 Contributing to the qualitative research
design (e.g. recruitment and consent strate-
gies, interview process, topic guide
development)
 Conducting the interviews (with appropriate
training provided)
 Interpreting the qualitative data to help
develop the conceptual model and framework
 Drafting the wording and format of the
PROM
 Revising the wording and format of the
PROM during an iterative cognitive interview
process
 Assessing the cross-cultural equivalence of a
translated PROM
 Finalizing the PROM
 Interpreting the psychometric properties of a
PROM (especially the Minimal (Clinical)
Important Change)
 Dissemination of the study ﬁndings and wider
public engagement
In summary, I think this article is well
intended and, although it might be a matter of
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semantics, the role of true patient involvement
in PROM development is important and it seems
to have been underemphasized.
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